HbA1c and the risks for all-cause and cardiovascular mortality in the general Japanese population: NIPPON DATA90

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3759-3765

  Sakurai, Masaru ^a,b   Saitoh, Shigeyuki ^c   Miura, Katsuyuki ^d   Nakagawa, Hideaki ^a   Ohnishi, Hirofumi ^c   Akasaka, Hiroshi ^c   Kadota, Aya ^e   Kita, Yoshikuni ^d   Hayakawa, Takehito ^f   Ohkubo, Takayoshi ^d,g   Okayama, Akira ^h   Okamura, Tomonori ⁱ   Ueshima, Hirotsugu ^d  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e OSAKA KYOIKU UNIVERSITY   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g TEIKYO UNIVERSITY   (Japan)

^h FUKUJUJI HOSPITAL   (Japan)

ⁱ KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EPIDEMIOLOGY; JAPAN; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; STROKE;

EID: 84891869989     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2412     Document Type: Article

References (38)

1. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327- 1334
2. Greenland P, Alpert JS, Beller GA, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010;122:2748- 2764
3. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality inmen inNorfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 2001;322: 15-18
4. Blake GJ, Pradhan AD, Manson JE, et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med 2004;164:757-761
5. Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol 2005;4:821- 826
6. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005;165:1910-1916
7. Myint PK, Sinha S, Wareham NJ, et al. Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study: a threshold relationship? Stroke 2007;38:271-275
8. Brewer N, Wright CS, Travier N, et al. A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care 2008;31: 1144-1149
9. Adams RJ, Appleton SL, Hill CL, et al. Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes. Obesity (Silver Spring) 2009;17:559-563
10. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
11. Nakanishi S, Yamada M, Hattori N, Suzuki G. Relationship between HbA(1)c and mortality in a Japanese population. Diabetologia 2005;48:230-234
12. Sunaga K, Miura K, Naruse Y, et al. Glycated hemoglobin and risk of stroke, ischemic and hemorrhagic, in Japanesemen and women. Cerebrovasc Dis 2008;26: 310-316
13. Watanabe M, Kokubo Y, Higashiyama A, Ono Y, Okayama A, Okamura T. New diagnosis criteria for diabetes with hemoglobin A1c and risks of macro-vascular complications in an urban Japanese cohort: the Suita study. Diabetes Res Clin Pract 2010;88:e20-e23
14. Kashiwagi A, Kasuga M, Araki E, et al.; Committee of the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012;3:39-40
15. Ueshima H, Sekikawa A, Miura K, et al. Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008; 118:2702-2709
16. Lida M, Ueda K, Okayama A, et al.; Nippon Data 80 Research Group. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese - Nippon data 80. J Hum Hypertens 2003;17:851-857
17. NIPPON DATA80 Research Group. Risk assessment chart for death from cardiovascular disease based on a 19-year followup study of a Japanese representative population. Circ J 2006;70:1249-1255
18. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Ueshima H; NIPPON DATA90 Research Group. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis 2006;184:143-150
19. Kadota A, Hozawa A, Okamura T, et al.; NIPPON DATA Research Group. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care 2007;30:1533-1538
20. Okamura T, Tanaka H, Miyamatsu N, et al.; NIPPON DATA80 Research Group. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007;190: 216-223
21. Takashima N, Miura K, Hozawa A, et al.; NIPPON DATA 90 Research Group. Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan: a 15-year follow up of NIPPONDATA90. BMCPublic Health 2010;10:306
22. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 2003;10:145-153
23. Okamura T, Hayakawa T, Kadowaki T, et al.; NIPPONDATA80 Research Group. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 2004;147: 1024-1032
24. Kilpatrick E, Bloomgarden Z, Zimmet P. Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ 2009;339:b4432
25. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular andmicrovascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412
26. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141: 421-431
27. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-489
28. Zoungas S, Chalmers J, Ninomiya T, et al.; ADVANCE Collaborative Group. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 2012;55:636-643
29. Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007;120: 720-727
30. Woerle HJ, Pimenta WP, Meyer C, et al. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values. Arch Intern Med 2004; 164:1627-1632
31. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161:397-405
32. Zia E, Pessah-Rasmussen H, Khan FA, et al. Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. Cerebrovasc Dis 2006; 21:18-25
33. Megherbi S-E, Milan C, Minier D, et al.; European BIOMED Study of Stroke Care Group. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 2003;34:688-694
34. Inagawa T. Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan. Neurosurg Rev 2007; 30:225-234
35. Hyvärinen M, Tuomilehto J, Mähönen M, et al.; DECODE Study Group. Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria. Stroke 2009;40:1633-1637
36. Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke 1994;25:951-957
37. Collins C. Pathophysiology and classification of stroke. Nurs Stand 2007;21:35-39
38. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774